Skip to content
Screener

AbCellera Biologics Inc. ABCL United States — Long-term assets

Similar metrics at other companies

Johnson Outdoors logo
JOUTUnited States: — Long-term assets
$176.14M+1.2%
Johnson Outdoors logo
JOUTCanada: — Long-term assets
$1.13M-2.4%
Johnson Outdoors logo
JOUTEurope: — Long-term assets
$5.86M-9.5%
Johnson Outdoors logo
JOUTOther: — Long-term assets
$9.12M+587%
FOS
FOSLUnited States — Long-term Assets
$95M+18.0%
Quad Graphics logo
QUADUnited States — Other long-term assets
$57.9M+36.2%

Other financials

Income statement

See full
Revenue$4.1M-76.3%
Operating income-$62.8M-26.6%
Net income-$55.4M-59.6%
EPS (diluted)-$0.18-50.0%

Balance sheet

See full
Cash & equivalents$145.1M+23.5%
Total debt$135.6M-4.5%
Total equity$896.0M-11.0%
Total assets$1.3B-6.7%

Cash flow

See full
Operating cash flow-$33.5M-190%
CapEx$2.1M-84.0%
Free cash flow-$37.4M-68.3%

Valuation

See full
Market cap$2.12B+112%
Enterprise value$2.11B+108%
P/S32×+1.6×

Profitability

See full
Operating margin-340.3%-127pp
Net margin-248.8%-83.6pp
FCF margin-238.9%-90.9pp

Returns & leverage

See full
Return on equity-17.3%+2.1pp
Debt / equity0.2×0.0×
Current ratio12.8×+1.7×

Where this comes from

Reported directly by AbCellera Biologics Inc. in its filing.

Tagged under the XBRL concept us-gaap:AssetsDesignatedToClosedBlockOtherLongTermInvestments.

The source filing: AbCellera Biologics Inc.’s 10-K, filed February 24, 2026.

Filed
Feb 24, 2026, 4:38 PM EST
Fiscal year
FY2025
Accession
0001703057-26-000012

Of the Company’s long-term assets at December 31, 2024, $505.1 million were located in Canada, $85.7 million in the U.S., and $18.4 million in other countries. Of the Company’s long-term assets at December 31, 2025, $532.1 million were located in Canada, $81.0 million in the U.S., and $15.6 million in other countries. In 2025, the Company's additions to property and equipment, contributions to joint ventures, and research and development expenses incurred in Canada were $36.6 million, $9.0 million, and $164.0 million, respectively, and nil, nil, and $22.8 million in foreign countries.

Item 16. Form 10-K Summary

FAQ

What is AbCellera Biologics Inc.'s united states — long-term assets?
AbCellera Biologics Inc. (ABCL) reported united states — long-term assets of $532.1M in Q4 2025.
How has AbCellera Biologics Inc.'s united states — long-term assets changed year-over-year?
AbCellera Biologics Inc.'s united states — long-term assets increased by 520.9% year-over-year, from $85.7M to $532.1M.
What does united states — long-term assets mean?
This metric measures the book value of non-current assets, such as property, plant, equipment, and intangible assets, located or utilized within the United States. It indicates the scale of the company's physical and strategic infrastructure investment required to support its domestic operations. Monitoring this balance provides insight into the capital intensity and long-term operational footprint of the business in this specific region.

Ask your AI about AbCellera Biologics Inc.'s united states — long-term assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude